Die homöopathische Behandlung von Depressionen

Zusammenfassung

Depressionen treten mit zunehmender Häufigkeit auf und stellen eine hohe sozioökonomische Belastung dar. Sie sind auch ein häufiger Grund, um eine homöopathische Behandlung in Anspruch zu nehmen. Nach einer Einführung in das Krankheitsbild der Depression und ihre Behandlungsmöglichkeiten werden anhand zweier grundlegender Modelle zur Entstehung depressiven Erlebens die Arzneimittelbilder von Carcinosinum und Arsenicum album herausgearbeitet.

Abstract

Depressions occur with increasing frequency and a high socio-economic burden. They are also a common reason for seeking homeopathic treatment. After introducing the clinical picture of depression and its treatment possibilities, the homeopathic remedy pictures of carcinosinum and arsenicum album are elaborated on the basis of two fundamental models of the development of depressive experiencing.

Schlüsselwörter

Depression - erlernte Hilflosigkeit - Melancholie - Carcinosinum - Arsenicum album

Key words

Depression - learned helplessness - melancholia - carcinosinum - arsenicum album

Publication History

Article published online:
18 November 2021

• Literatur

• 1 Abermann C. Carcinosinum: Ein immer noch unterschätztes Polychrest (Teil 1). ZKH 2010; 54: 117-131
• 2 Bagherian M, Mojembari AK, Hakami M. The effects of homeopathic medicines on reducing the symptoms of anxiety and depression: Randomized, double blind and placebo controlled. Journal of Homeopathy and Ayurvedic Medicine 2014; 3: 4
• 3 Cipriani A, Furukawa TA, Salanti G. et al Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. Lancet 2018; 391: 1357-1366
• 4 Davidson JR, Crawford C, Ives JA, Jonas WB. Homeopathic treatments in psychiatry: A systematic review of randomized placebo-controlled studies. J Clin Psychiatry 2011; 72: 795-805
• 5 Davies J, Read J. A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?. Addictive Behaviours 2019; 97: 111-121
• 6 Dilling H, Mombour W, Schmidt MH. Hrsg Internationale Klassifikation psychischer Störungen: ICD10 Kapitel V Klinisch diagnostische Leitlinien. 10. Aufl. Göttingen: Hofgrefe; 2015
• 7 DGPPN, BÄK, KBV, AWMF, Hrsg. für die Leitliniengruppe Unipolare Depression. S3-Leitlinie/Nationale Versorgungs Leitlinie Unipolare Depression – Langfassung. 2. Aufl. Version 5. 2015 10.6101/AZQ/000364
• 8 Gøtzsche PC. Tödliche Psychopharmaka und organisiertes Leugnen. München: Riva; 2016
• 9 Hahnemann S. Organon der Heilkunst. Stuttgart: Haug; 2004
• 10 Kirsch I. The Emperor’s New Drugs. New York: Basic Books; 2010
• 11 Kirsch I. Der Placeboeffekt in der antidepressiven Behandlung. Verhaltenstherapie 2016; 26: 55-61
• 12 Koch U. Die zeitgemäße homöopathische Behandlung schwerer psychischer Störungen. AHZ 2012; 257: 6-11
• 13 Koch U. Zur Integration von Homöopathie und Psychiatrie in der Behandlung schwerer psychischer Störungen. ZKH 2018; 62: 55-59
• 14 Lalor L. Homoeopathic Psychiatry. Assesse: B. Jain Archibel; 2009
• 15 Maier SF, Seligman MEP. Learned helplessness at fifty: Insights from neuroscience. Psychol Rev 2016; 123: 349-367
• 16 Munkholm K, Paludan-Müller AS, Boesen K. Considering the methodological limitations in the evidence base of antidepressants for depression: A reanalysis of a network meta-analysis. BMJ Open 2019; 9: e024886
• 17 Oberai P, Balachandran I, Janardhanan Nair KR. et al Homoeopathic management in depressive episodes: A prospective, unicentric, non-comparative, open-label observational study. Indian Journal of Research in Homoeopathy 2014; 7: 116-125
• 18 Pilkington K, Kirkwood G, Rampes H. et al Homeopathy for depression: A systematic review of the research evidence. Homeopathy 2005; 94: 153-163
• 19 Qato DM, Ozenberger K, Olfson M. Prevalence of prescription medications with depression as a potential adverse effect among adults in the United States. JAMA 2018; 319: 2289-2298
• 20 Rathmer D. Rathmer’s Repertorium. Billerbeck: Verlagshaus Rathmer; 2011
• 21 Rotella F, Cassioli E, Falone A. et al Homeopathic remedies in psychiatric disorders: A meta-analysis of randomized controlled trials. Journal of Clinical Psychopharmacology 2020; 40: 269-275
• 22 Schwabe U, Ludwig WD. Arzneiverordnungs-Report 2020. Berlin: Springer; 2020
• 23 Seideneder A. Mitteldetails der homöopathischen Arzneimittel. Ruppichteroth: Similimun-Verlag; 2000
• 24 Teixeira MZ. Antidepressants, suicidality and rebound effect: Evidence of similitude?. Homeopathy 2009; 98: 114-121
• 25 Tellenbach H. Melancholie, Problemgeschichte, Endogenität, Typologie, Pathogenese, Klinik. 4. Aufl Berlin: Springer; 1983
• 26 Viksveen P, Relton C. Depression treated by homeopaths: A study protocol for a pragmatic cohort multiple randomized controlled trial. Homeopathy 2014; 103: 147-152
• 27 Viksveen P, Relton C, Nicholl J. Depressed patients treated by homeopaths: A randomized controlled trial using the „cohort multiple randomized controlled trial“ (cmRCT) design. Trials 2017; 18: 299
• 28 Viksveen P, Fibert P, Relton C. Homeopathy in the treatment of depression: A systematic review. European Journal of Integrative Medicine 2018; 22: 22-36
• 29 Zhou X, Teng T, Zhang Y. et al Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: A systematic review and network meta-analysis. Lancet Psychiatry 2020; 7: 581-601